FRANCE. Frown, squint, laugh”¦. repeated facial movements are prone to cause dermo-creases, better known as laugh lines, crow’s feet and brow furrows. Lancôme, after years of research and 12 pending patents later, has found a new solution, gentler than Botox.
Resolution D-Contraxol is the first intensive anti-wrinkle treatment with D-Contraxol, an exclusive skin-relaxing technology, to target to women aged 35-45 with fine lines and wrinkles. This revolution works on dermo-creases to visibly reduce wrinkles in depth and number.
Starting from May, Resolution D-Contraxol will be launched in Asia in both local markets and travel retail. Scental – Lancôme Division manager Philippe Archambault commented:”High profile promotions and major counter decoration will take place in key airport locations to emphasize on this growth opportunity for the Asian skincare market”.
“Being a huge success in the US and Europe, Resolution D-Contraxol is loved by both press and consumers”, says Scental Lancôme marketing manager Isabelle Castot.
It is suggested to be able to deliver wrinkle-erasing result similar to Botox. Resolution D-Contraxol has already become the top three best-selling anti-aging moisturizer in the US market just one month after its launch. Vogue USA has highlighted Resolution D-Contraxol as “The Skin Cream That Could Change Everything” on its cover in the February 2003 issue.
